Company intelligence / Profile preview

Zhuhai Essex Bio-Pharmaceutical Co., Ltd.

Zhuhai, Guangdong Province, Chinaessexbio.com ↗

Ownership: Private
Employees: ~1000
Development stage: Commercial

Overview

EssexBio has six commercialized biologics since the late '90s—mainly recombinant bovine basic fibroblast growth factor—for wound healing and ophthalmic use. Recent clinical progress includes positive Phase III results for bevacizumab intravitreal injection for wet AMD, approval of preservative-free sodium hyaluronate eye drops in China, cyclosporine eye drops in Phase II trials, azithromycin eye drops under regulatory review, plus ongoing expansion into oncology with outlicensed bispecific antibody assets.

Therapeutic areas: OncologyOtherDermatologyOphthalmologyNeurologyInfectious Diseases
Modalities: Biologics (recombinant growth factors, e.g. rb-bFGF/FGF2)Small moleculesAntibodies/bi-/multi-specific antibodiesSynthetic peptidesNon-degrading molecular glue
Industry: Biotech

Drug pipeline

1 asset

Bovine Basic Gel

Unknown

Partnerships

Kelun-Biotech – global out-license agreement for bispecific antibody candidate EB12–10101Z targeting oncology/ophthalmology applications.Mitotech – exclusive global rights to SkQ1 compound in ophthalmology field.Osteopore Pte Ltd.

Beyond the preview

Go deeper on Zhuhai Essex Bio-Pharmaceutical Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhuhai Essex Bio-Pharmaceutical Co., Ltd..

Explore the full profile